Ash Tewari, MBBS, MCh

System Chair, Milton & Carroll Petrie Department of Urology

Director of Robotic Prostatectomy, Precision UrologyTM & Men’s Health, Mount Sinai Health System

Director, Prostate Cancer Program, The Barbara and Maurice A. Deane Prostate Health and Research Center, Mount Sinai Health System

Professor of Urology, Department of Urology at the Icahn School of Medicine at Mount Sinai

Research Interest: Prostate Cancer

Expertise: Prostate Cancer, Kidney Cancer, Laparoscopic Techniques, Robotic Surgery, Cystoscopy, Prostatectomy, Prostate Biopsy

  • Friday, February 19th 1:40–2:50 pm

    Prostate Session II – Retzius Sparing


    Avoiding the Retzius structures involved in continence and potency preservation and passing through the pouch of Douglas can be oncologically safe and can result in high early continence and potency rates.

  • Saturday, February 20th 8:10–10:20 am

    Prostate Session III – Single Port


    Surgical treatment for prostate cancer is transforming. The novel da Vinci Surgical System for single port system is safe and feasible. The approach presents satisfactory outcomes for: operative time, hospital stay, pain requirements, catheterisation time, and complications. Patients have reported favourable ratings for scar cosmesis as compared to conventional laparoscopic or open approaches after kidney surgery.